Form 4: Edwards Lifesciences CFO Scott B. Ullem Reports Changes in Beneficial Ownership

CVP and Chief Financial Officer of Edwards Lifesciences, Scott B. Ullem, reports changes in beneficial ownership of company stock due to tax withholding.

Summary

• Scott B. Ullem, CVP and Chief Financial Officer of Edwards Lifesciences, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• The reported transactions involve the disposal of common stock to cover tax obligations.
• On May 3, 2025, 635 shares were disposed of at a price of $75.65.
• On May 4, 2025, 648 shares were disposed of at a price of $75.65.
• Following these transactions, Ullem directly owns 29,104 shares and indirectly owns 266,318 shares through a trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions for tax purposes, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates stock disposals for tax purposes, which is a common practice among executives.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to tax obligations and do not reflect a change in the company's fundamentals.

Key Dates

Keywords

Form 4, Beneficial Ownership, Edwards Lifesciences, Scott B. Ullem, Stock Disposal, Tax Withholding, CFO, EW